Angela Gismondi
Overview
Explore the profile of Angela Gismondi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Laffranchi M, Paraboschi E, Bianchetto-Aguilera F, Tamassia N, Gasperini S, Gardiman E, et al.
Heliyon
. 2025 Jan;
11(1):e41267.
PMID: 39811276
The 3p21.31 locus is the most robust genomic region associated with COVID-19 severity. This locus contains a main chemokine receptor (CKR) cluster. We tested expression quantitative trait loci (eQTL) targeting...
2.
Passari M, Scutera S, Schioppa T, Tiberio L, Piantoni S, Tamassia N, et al.
Sci Rep
. 2024 Nov;
14(1):28610.
PMID: 39562651
No abstract available.
3.
Passari M, Scutera S, Schioppa T, Tiberio L, Piantoni S, Tamassia N, et al.
Sci Rep
. 2024 Nov;
14(1):26820.
PMID: 39500942
Neutrophils (PMNs) are key players of innate immune responses through the release of cytoplasmic granule content and the formation of neutrophil extracellular traps (NETs). RNASET2 is an acidic ribonuclease, recently...
4.
Scarno G, Mazej J, Laffranchi M, Di Censo C, Mattiola I, Candelotti A, et al.
Proc Natl Acad Sci U S A
. 2023 Sep;
120(40):e2306761120.
PMID: 37756335
Natural killer (NK) cells and type 1 innate lymphoid cells (ILC1) require signal transducer and activator of transcription 4 (STAT4) to elicit rapid effector responses and protect against pathogens. By...
5.
Sozio F, Schioppa T, Laffranchi M, Salvi V, Tamassia N, Bianchetto-Aguilera F, et al.
Cancer Immunol Res
. 2023 Jun;
11(9):1280-1295.
PMID: 37343073
Patterns of receptors for chemotactic factors regulate the homing of leukocytes to tissues. Here we report that the CCRL2/chemerin/CMKLR1 axis represents a selective pathway for the homing of natural killer...
6.
Cippitelli M, Stabile H, Kosta A, Petillo S, Lucantonio L, Gismondi A, et al.
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36768145
Nuclear factor-κB (NF-κB) transcription factors play a key role in the pathogenesis of multiple myeloma (MM). The survival, proliferation and chemoresistance of malignant plasma cells largely rely on the activation...
7.
Fionda C, Ruggeri S, Sciume G, Laffranchi M, Quinti I, Milito C, et al.
Front Immunol
. 2022 Dec;
13:1039120.
PMID: 36466890
Natural Killer (NK) cells are key innate effectors of antiviral immune response, and their activity changes in ageing and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Here, we investigated...
8.
Milito N, Zingoni A, Stabile H, Soriani A, Capuano C, Cippitelli M, et al.
Eur J Immunol
. 2022 Nov;
53(2):e2250198.
PMID: 36440686
Natural killer (NK) cell activation is regulated by activating and inhibitory receptors that facilitate diseased cell recognition. Among activating receptors, NKG2D and DNAM-1 play a pivotal role in anticancer immune...
9.
Kosta A, Mekhloufi A, Lucantonio L, Zingoni A, Soriani A, Cippitelli M, et al.
Front Immunol
. 2022 Aug;
13:942640.
PMID: 35967396
NKG2D ligands play a relevant role in Natural Killer (NK) cell -mediated immune surveillance of multiple myeloma (MM). Different levels of regulation control the expression of these molecules at cell...
10.
Fionda C, Scarno G, Stabile H, Molfetta R, Di Censo C, Gismondi A, et al.
Int J Mol Sci
. 2022 Jul;
23(14).
PMID: 35887206
Colorectal cancer (CRC) is one of the most common malignancies and leading causes of cancer-related deaths worldwide. Despite its complex pathogenesis and progression, CRC represents a well-fitting example of how...